研發創新

研發創新

倍斯特醫藥生技(BMB)已成立研發中心專注於投入慢性病藥物開發,並以生體相等性(BE)認證提升藥品品質,證明產品與歐、美、日原開發廠具有相等水準。並陸續開發一些較高門檻技術,如緩釋劑型及特殊劑型等產品。 未來將加強與原開發廠在通路行銷策略上的合作、資訊交流,期盼透過專業研發及行銷團隊共同為明日的健康而努力。

R&D, Innovation

The Best Medicine Biotechnology Co., Ltd. (BMB) has established the R&D department to be engaged in the development of chronic diseases medicine, and enhance the medicine quality by offering the Bioequivalence (BE) Authentication pharmaceuticals to prove our products have the same level as the original factory in Europe, America, and Japan. In addition, BMB also develop some high-tech products, such as slow-release dosage form and special formulations.
In the future, BMB will enforce cooperation and information exchange with original factory on the channel-marketing. We are looking forward to work hard together for tomorrow's health through professional research, development and marketing team.